Literature DB >> 23500642

Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.

Wolfgang Jäger1, Yutaka Horiguchi, Jay Shah, Tetsutaro Hayashi, Shannon Awrey, Kilian M Gust, Boris A Hadaschik, Yoshiyuki Matsui, Shawn Anderson, Robert H Bell, Susan Ettinger, Alan I So, Martin E Gleave, I-Ling Lee, Colin P Dinney, Masaaki Tachibana, David J McConkey, Peter C Black.   

Abstract

PURPOSE: KU7 is a popular urothelial carcinoma cell line that was isolated from the bladder of a patient at Keio University in 1980. It has subsequently been widely used in laboratories around the world. We describe how routine cell line authentication revealed that KU7 was cross contaminated almost 30 years ago with HeLa, a cervical carcinoma cell line.
MATERIALS AND METHODS: Presumed KU7 clones dating from 1984 to 1999 were provided by M.D. Anderson Cancer Center, Vancouver Prostate Centre, Kyoto University, Tokyo Medical University and Keio University. HeLa was obtained from ATCC. Genomic DNA was isolated and short tandem repeat analysis was performed at the M.D. Anderson Cancer Center Characterized Cell Line Core Facility, Johns Hopkins University Fragment Analysis Facility and RIKEN BioResource Center, Ibaraki, Japan. Comparative genomic hybridization was performed on a platform (Agilent Technologies, Santa Clara, California) at Vancouver Prostate Centre.
RESULTS: The short tandem repeat profile of all KU7 clones was an exact match with that of HeLa. Comparative genomic hybridization of all samples revealed an abundance of shared chromosomal aberrations. Slight differences in some genomic areas were explained by genomic drift in different KU7 clones separated by many years.
CONCLUSIONS: Our analysis identified that cross contamination of KU7 with HeLa occurred before 1984 at the source institution. All KU7 clones in the urological literature should be considered HeLa and experimental results should be viewed in this light. Our results emphasize the need to authenticate cell lines in oncological research.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMEL; DNA contamination; HeLa cells; KU; Keio University; M.D. Anderson Cancer Center; MDACC; STR; VPC; Vancouver Prostate Centre; aCGH; amelogenin; array comparative genomic hybridization; carcinoma; short tandem repeat; urinary bladder; urothelium

Mesh:

Year:  2013        PMID: 23500642      PMCID: PMC3805942          DOI: 10.1016/j.juro.2013.03.009

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

1.  Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.

Authors:  Geertje van der Horst; Joost J van Asten; Anne Figdor; Christel van den Hoogen; Henry Cheung; Rob F M Bevers; Rob C M Pelger; Gabri van der Pluijm
Journal:  Eur Urol       Date:  2011-05-19       Impact factor: 20.096

2.  In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.

Authors:  Clement Mugabe; Yoshiyuki Matsui; Alan I So; Martin E Gleave; Jennifer H E Baker; Andrew I Minchinton; Irina Manisali; Richard Liggins; Donald E Brooks; Helen M Burt
Journal:  Clin Cancer Res       Date:  2011-02-28       Impact factor: 12.531

Review 3.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-03-22       Impact factor: 20.096

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.

Authors:  Liana Adam; Peter C Black; Wassim Kassouf; Beryl Eve; David McConkey; Mark F Munsell; William F Benedict; Colin P N Dinney
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

6.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

7.  Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

8.  A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.

Authors:  Boris A Hadaschik; Peter C Black; Jason C Sea; Adam R Metwalli; Ladan Fazli; Colin P Dinney; Martin E Gleave; Alan I So
Journal:  BJU Int       Date:  2007-09-10       Impact factor: 5.588

9.  Genetic instability and divergence of clonal populations in colon cancer cells in vitro.

Authors:  Laia Masramon; Elisenda Vendrell; Gemma Tarafa; Gabriel Capellà; Rosa Miró; Maria Ribas; Miguel A Peinado
Journal:  J Cell Sci       Date:  2006-03-21       Impact factor: 5.285

10.  Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix.

Authors:  W F SCHERER; J T SYVERTON; G O GEY
Journal:  J Exp Med       Date:  1953-05       Impact factor: 14.307

View more
  16 in total

1.  HeLa nucleic acid contamination in the cancer genome atlas leads to the misidentification of human papillomavirus 18.

Authors:  Paul G Cantalupo; Joshua P Katz; James M Pipas
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

2.  Cell-line authentication demystified.

Authors:  Vivien Marx
Journal:  Nat Methods       Date:  2014-04-29       Impact factor: 28.547

3.  Structured illumination temporal compressive microscopy.

Authors:  Xin Yuan; Shuo Pang
Journal:  Biomed Opt Express       Date:  2016-02-03       Impact factor: 3.732

Review 4.  Targeted therapies in bladder cancer: an overview of in vivo research.

Authors:  Kim E M van Kessel; Tahlita C M Zuiverloon; Arnout R Alberts; Joost L Boormans; Ellen C Zwarthoff
Journal:  Nat Rev Urol       Date:  2015-09-22       Impact factor: 14.432

5.  Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Authors:  Peter A Raven; Ninadh M D'Costa; Igor Moskalev; Zheng Tan; Sebastian Frees; Claudia Chavez-Munoz; Alan I So
Journal:  Am J Clin Exp Urol       Date:  2018-12-20

6.  P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.

Authors:  Byung Hoon Chi; Soon-Ja Kim; Ho Kyung Seo; Hye-Hyun Seo; Sang-Jin Lee; Jong Kyou Kwon; Tae-Jin Lee; In Ho Chang
Journal:  J Korean Med Sci       Date:  2015-02-16       Impact factor: 2.153

7.  The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.

Authors:  Julie Earl; Daniel Rico; Enrique Carrillo-de-Santa-Pau; Benjamín Rodríguez-Santiago; Marinela Méndez-Pertuz; Herbert Auer; Gonzalo Gómez; Herbert Barton Grossman; David G Pisano; Wolfgang A Schulz; Luis A Pérez-Jurado; Alfredo Carrato; Dan Theodorescu; Stephen Chanock; Alfonso Valencia; Francisco X Real
Journal:  BMC Genomics       Date:  2015-05-22       Impact factor: 3.969

8.  Minimally invasive establishment of murine orthotopic bladder xenografts.

Authors:  Wolfgang Jäger; Igor Moskalev; Claudia Janssen; Tetsutaro Hayashi; Killian M Gust; Shannon Awrey; Peter C Black
Journal:  J Vis Exp       Date:  2014-02-11       Impact factor: 1.355

9.  Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.

Authors:  Wolfgang Jäger; Igor Moskalev; Claudia Janssen; Tetsutaro Hayashi; Shannon Awrey; Kilian M Gust; Alan I So; Kaixin Zhang; Ladan Fazli; Estelle Li; Joachim W Thüroff; Dirk Lange; Peter C Black
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 10.  Reliable in vitro studies require appropriate ovarian cancer cell lines.

Authors:  Francis Jacob; Sheri Nixdorf; Neville F Hacker; Viola A Heinzelmann-Schwarz
Journal:  J Ovarian Res       Date:  2014-06-07       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.